Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||||
---|---|---|---|---|---|---|---|---|
fig.8.b
Das S and Chang C (2012) |
Xla Wt + smurf2 MO
neurula stage (in situ hybridization) |
|||||||
fig.8.b
Das S and Chang C (2012) |
Xla Wt + smurf2 MO
neurula stage (in situ hybridization) |
|||||||
fig.8.b
Das S and Chang C (2012) |
Xla Wt + smurf2 MO
neurula stage (in situ hybridization) |
|
||||||
fig.6.h
Steventon B and Mayor R (2012) |
Xla Wt + Hsa.DKK1
NF13 (in situ hybridization) |
|
||||||
fig.7.b
Agüero TH et al. (2012) |
Xla Wt + Cyclopamine
NF13 (in situ hybridization) |
|
||||||
fig.7.e
Agüero TH et al. (2012) |
Xla Wt + Cyclopamine
NF14 (in situ hybridization) |
|
||||||
fig.7.k
Agüero TH et al. (2012) |
Xla Wt + Cyclopamine
NF17 (in situ hybridization) |
|
||||||
fig.9.a
Agüero TH et al. (2012) |
Xla Wt + Cyclopamine
NF24 (in situ hybridization) |
|
||||||
fig.5.b
Agüero TH et al. (2012) |
Xla Wt + ihh
NF16 (in situ hybridization) |
|
||||||
fig.3.h
Agüero TH et al. (2012) |
Xla Wt + ihh MO
NF16 (in situ hybridization) |
|